Deal snapshot: Kanvas Biosciences Acquires 2 Active Therapeutics Programmes from Federation Bio to Accelerate Immuno-Oncology Programme.

MANews-(C)2009-2023

US-based microbiome mapping technology company Kanvas Biosciences has acquired two active therapeutics programmes, a microbial library, and intellectual property from California-based live biotherapeutics products manufacturer Federation Bio, the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT